This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The nation’s publicly traded hospicecompanies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. raise compared to Q1 in 2023. million and $54.6
This year brought the return of Medicare sequestration, and pandemic-driven disruption in referral streams are lingering. This expense and associated drops in patient volume put a dent in third quarter revenues, but CFO Jeff Shaner has indicated that enduring that disruption will set up Aveanna for a healthier 2023. . “In
After a rocky year for M&A, two of the publicly traded hospice providers are poised to pursue more deals in 2024. Based on 2023 earnings trends, The Pennant Group (NASDAQ: PNTG) and Addus HomeCare Cop. The company was among the most prolific hospice buyers last year and has established growth through acquisitions as a key strategy.
Most hospices are sliding into 2023 between a rock and a hard place, beset by headwinds, labor shortages and questions with no easy answers. Government oversight of hospice providers will tighten during 2023. A coalition of hospice industry organizations recently urged the U.S. Be ready for regulation.
Montana-headquartered Stillwater Hospice has found a successful rhythm to strategic rural-based growth and sustainability. Launched in 2017, the hospicecompany serves predominantly rural-based populations in Montana, northern Wyoming and South Dakota. From a cost standpoint, paying for that mileage is very expensive.
Also on the table is the question of how to meet the needs of Medicare beneficiaries who increasingly seek to receive care in their homes, according to Center for Medicare & Medicaid Innovation (CMMI) Director Elizabeth Fowler. “In Going forward, this could mean greater collaboration with private-sector payers and providers. .
Hospices are blazing trails toward growth, each provider with its own range of strategies. In 2023, the focus for many is to not only expand their core business but to spread further into the care continuum. In this story, Hospice News highlights the growth strategies of several providers.
The prior three years have laid the groundwork for change, particularly in the regulatory space as well as gradual migration towards value-based reimbursement and in tandem, the proliferation of business lines beyond hospice. With these factors in mind, below are four key trends hospices should watch this year.
Hospices and Accountable Care Organizations have the ability to customize payment contracts within the Realizing Equity, Access and Community Health (ACO REACH) program. 1, 2023, the U.S. Centers for Medicare & Medicaid Services (CMS) is replacing the Global and Professional Direct Contracting (GPDC) model with ACO REACH.
Some hospicecompany leaders have signaled the labor market may be showing signs of stabilization. The note showed that the high rate of inflation is driving higher than average payment rate increases with insurance plans in their 2023 contracts.
In 2022, the hospice community laid the groundwork for a transformational 2023. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice regulations that will become effective on Jan. The insurance company will integrate LHC Group with its existing home health asset, Optum Health.
Four national hospice and senior care industry groups have called on Congress and the U.S. Centers for Medicare & Medicaid Services (CMS) to make regulatory and legislative changes to instill stronger program integrity safeguards. The Hospice Program Integrity plan lists 34 recommendations that center around five key areas.
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. billion to $1.08
Hospices simply did not have enough staff to meet demand, which drove some of them out of business. Executives from almost every publicly traded hospicecompany raised this issue in earnings calls and presentations throughout the year. Centers for Medicare & Medicaid Services (CMS). NYSE: CHEM) VITAS Healthcare. “So
The Texas-based home health and hospicecompany VitalCaring Group was built largely through acquisitions, and the company expects to step up that strategy in 2024 with an emphasis on hospice. What are some of your priorities for your hospice business in particular when it comes to growth during 2024?
SEIU analyzed Medicare claims data showing that the average hospice transfer rate among HCA hospital discharges was nearly 40% above the national average in 2021 and represented a 50% growth rate over four years. For one, hospice utilization has been on a steady upswing nationally for several years. told Hospice News.
There are a lot of home health and hospicecompanies where the idea is just to get bigger and put more dots on the map. I think many providers were disappointed by the 2023 reimbursement rates with cuts to home health and a hospice increase that many said were insufficient in today’s environment.
The recent entry of large numbers of newly created hospice organizations in several states has heightened long-standing concerns among hospice leaders (as shared with CMS in November 2022) about the adequacy of Medicare certification, accreditation, and enforcement processes.
Centers for Medicare & Medicaid Services (CMS). With everything that’s changing in the industry right now, I’m more heavily involved in the decision-making with our hospices and how their care plans handle specific situations as they arise each and every day. What has changed the most since you came into the hospice industry?
Hospice leaders will need to keep their eyes on five key trends in the new year when it comes to compliance, business operations and finance. Hospice utilization reached 51.7% The number of hospice care days also saw increases, as did average length of stay and average number of patient visits per week.
The nations hospice utilization rate among Medicare decedents has once again surpassed 50%, for the first time since the pandemic. Hospice utilization reached 51.7% in 2023, up more than two percentage points from the prior year, according to recent data from the Medicare Payment Advisory Commission (MedPAC).
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content